A39.2 Acute meningococcemia

Name of the Condition

• Acute meningococcemia

Summary

Acute meningococcemia is a severe, rapidly progressing bloodstream infection caused by Neisseria meningitidis. It is characterized by the presence of meningococcal bacteria in the blood and can lead to systemic inflammation, sepsis, and organ dysfunction. Prompt medical intervention is critical due to its potential for life-threatening complications.

Causes

Acute meningococcemia is caused by the bacterium Neisseria meningitidis. Transmission occurs through respiratory droplets or direct contact with secretions from an infected person. The bacteria colonize the nasopharynx before invading the bloodstream, triggering a systemic inflammatory response.

Risk Factors

• Close or prolonged contact with an infected individual (e.g., household members, roommates).
• Living in crowded settings (e.g., dormitories, military barracks).
• Travel to regions with high rates of meningococcal disease.
• Lack of vaccination against meningococcal disease.
• Certain medical conditions (e.g., complement deficiencies, asplenia).

Symptoms

• Sudden high fever.
• Chills and rigors.
• Severe malaise and fatigue.
• Skin rash (may appear as small, dark red or purple spots that do not blanch under pressure).
• Hypotension (low blood pressure) or shock.
• Altered mental status or confusion.
• Nausea, vomiting, or abdominal pain.

Diagnosis

Diagnosis involves clinical evaluation and laboratory testing. Blood cultures are the primary method to detect Neisseria meningitidis. Additional tests may include complete blood counts, coagulation studies, and inflammatory markers. Lumbar puncture may be performed if meningitis is suspected, but acute meningococcemia can occur without meningeal involvement.

Treatment Options

Treatment requires immediate administration of intravenous antibiotics, such as ceftriaxone or penicillin, to target Neisseria meningitidis. Supportive care, including fluid resuscitation, vasopressors for hypotension, and management of organ dysfunction, is critical. Close monitoring in an intensive care setting is often necessary.

Prognosis and Follow-Up

Prognosis depends on the speed of treatment and severity of complications. Early antibiotic therapy improves outcomes, but mortality remains significant in severe cases. Survivors may require long-term follow-up for complications like limb loss, hearing loss, or neurological deficits. Close monitoring for recurrence or secondary infections is recommended.

Complications

• Septic shock and multiorgan failure.
• Disseminated intravascular coagulation (DIC).
• Acute respiratory distress syndrome (ARDS).
• Meningitis (if the infection spreads to the meninges).
• Limb ischemia or amputation due to vascular occlusion.
• Hearing loss or neurological damage.

Lifestyle & Prevention

• Vaccination against Neisseria meningitidis (e.g., MenACWY, MenB vaccines) is the most effective preventive measure.
• Avoid close contact with individuals showing symptoms of meningococcal disease.
• Practice good hand hygiene to reduce transmission risk.
• Seek prompt medical care for symptoms suggestive of infection.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden high fever, severe headache, stiff neck, skin rash, or signs of shock (e.g., dizziness, rapid heart rate, confusion). Meningococcemia progresses rapidly, and delays in treatment can increase the risk of severe complications or death.

Tips for Medical Coders

Use code A39.2 for acute meningococcemia, which specifically denotes a bloodstream infection without meningeal involvement. Document the presence of bacteremia, systemic inflammatory response, and absence of meningitis to support coding. Include details on clinical presentation, laboratory confirmation, and treatment to ensure accurate code assignment.